ENSG00000136492 |
BRIP1 |
Ovarian Endometrioid Adenocarcinoma |
missense_variant |
37.5% (6/16) |
1 entry |
ENSG00000136492 |
BRIP1 |
breast ductal adenocarcinoma |
sequence_alteration |
6.448% (102/1582) |
3 entries |
ENSG00000136492 |
BRIP1 |
pancreatic ductal adenocarcinoma |
missense_variant |
3.983% (67/1682) |
2 entries |
ENSG00000136492 |
BRIP1 |
breast ductal adenocarcinoma |
stop_gained |
6.448% (102/1582) |
1 entry |
ENSG00000136492 |
BRIP1 |
esophageal adenocarcinoma |
missense_variant |
6.055% (33/545) |
1 entry |
ENSG00000136492 |
BRIP1 |
breast ductal adenocarcinoma |
missense_variant |
6.448% (102/1582) |
1 entry |
ENSG00000136492 |
BRIP1 |
Ovarian Endometrioid Adenocarcinoma |
sequence_alteration |
37.5% (6/16) |
1 entry |
ENSG00000136492 |
BRIP1 |
lung adenocarcinoma |
missense_variant |
2.017% (52/2578) |
5 entries |
ENSG00000136492 |
BRIP1 |
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
3.87% (25/646) |
1 entry |
ENSG00000136492 |
BRIP1 |
colorectal adenocarcinoma |
stop_gained |
2.556% (31/1213) |
2 entries |
ENSG00000136492 |
BRIP1 |
colon adenocarcinoma |
frameshift_variant |
2.401% (31/1291) |
2 entries |
ENSG00000136492 |
BRIP1 |
small cell lung carcinoma |
missense_variant |
1.121% (5/446) |
1 entry |
ENSG00000136492 |
BRIP1 |
squamous cell lung carcinoma |
missense_variant |
1.005% (10/995) |
2 entries |
ENSG00000136492 |
BRIP1 |
skin melanoma |
missense_variant |
3.02% (35/1159) |
5 entries |
ENSG00000136492 |
BRIP1 |
Uterine Carcinosarcoma |
missense_variant |
8.108% (12/148) |
1 entry |
ENSG00000136492 |
BRIP1 |
urothelial carcinoma |
missense_variant |
2.326% (2/86) |
1 entry |
ENSG00000136492 |
BRIP1 |
lung adenocarcinoma |
frameshift_variant |
2.017% (52/2578) |
2 entries |
ENSG00000136492 |
BRIP1 |
central nervous system primitive neuroectodermal neoplasm |
sequence_alteration |
1.786% (8/448) |
1 entry |
ENSG00000136492 |
BRIP1 |
colorectal adenocarcinoma |
frameshift_variant |
2.556% (31/1213) |
2 entries |
ENSG00000136492 |
BRIP1 |
esophageal squamous cell carcinoma |
missense_variant |
1.308% (9/688) |
5 entries |
ENSG00000136492 |
BRIP1 |
pancreatic neuroendocrine tumor |
missense_variant |
5.085% (12/236) |
1 entry |
ENSG00000136492 |
BRIP1 |
bile duct adenocarcinoma |
frameshift_variant |
0.5195% (2/385) |
2 entries |
ENSG00000136492 |
BRIP1 |
anaplastic oligodendroglioma |
missense_variant |
2.353% (2/85) |
1 entry |
ENSG00000136492 |
BRIP1 |
hepatocellular carcinoma |
missense_variant |
1.32% (13/985) |
1 entry |
ENSG00000136492 |
BRIP1 |
breast carcinoma |
sequence_alteration |
1.085% (16/1474) |
1 entry |
ENSG00000136492 |
BRIP1 |
gastric adenocarcinoma |
missense_variant |
0.8345% (6/719) |
1 entry |
ENSG00000136492 |
BRIP1 |
bladder transitional cell carcinoma |
missense_variant |
1.794% (8/446) |
2 entries |
ENSG00000136492 |
BRIP1 |
Breast Carcinoma by Gene Expression Profile |
missense_variant |
12.24% (6/49) |
2 entries |
ENSG00000136492 |
BRIP1 |
renal carcinoma |
missense_variant |
10.0% (2/20) |
2 entries |
ENSG00000136492 |
BRIP1 |
melanoma |
missense_variant |
3.448% (5/145) |
3 entries |
ENSG00000136492 |
BRIP1 |
colorectal adenocarcinoma |
sequence_alteration |
2.556% (31/1213) |
1 entry |
ENSG00000136492 |
BRIP1 |
ovarian serous adenocarcinoma |
stop_gained |
2.162% (19/879) |
1 entry |
ENSG00000136492 |
BRIP1 |
prostate adenocarcinoma |
sequence_alteration |
2.932% (63/2149) |
1 entry |
ENSG00000136492 |
BRIP1 |
cecum adenocarcinoma |
frameshift_variant |
3.717% (10/269) |
1 entry |
ENSG00000136492 |
BRIP1 |
brain glioblastoma |
missense_variant |
0.495% (6/1212) |
2 entries |
ENSG00000136492 |
BRIP1 |
skin melanoma |
sequence_alteration |
3.02% (35/1159) |
1 entry |
ENSG00000136492 |
BRIP1 |
Breast Carcinoma by Gene Expression Profile |
sequence_alteration |
12.24% (6/49) |
1 entry |
ENSG00000136492 |
BRIP1 |
head and neck squamous cell carcinoma |
missense_variant |
0.8011% (6/749) |
1 entry |
ENSG00000136492 |
BRIP1 |
pancreatic ductal adenocarcinoma |
frameshift_variant |
3.983% (67/1682) |
1 entry |
ENSG00000136492 |
BRIP1 |
colon adenocarcinoma |
missense_variant |
2.401% (31/1291) |
8 entries |
ENSG00000136492 |
BRIP1 |
bladder carcinoma |
missense_variant |
3.02% (17/563) |
1 entry |
ENSG00000136492 |
BRIP1 |
basal cell carcinoma |
missense_variant |
4.412% (3/68) |
1 entry |
ENSG00000136492 |
BRIP1 |
head and neck squamous cell carcinoma |
sequence_alteration |
0.8011% (6/749) |
1 entry |
ENSG00000136492 |
BRIP1 |
prostate adenocarcinoma |
missense_variant |
2.932% (63/2149) |
2 entries |
ENSG00000136492 |
BRIP1 |
melanoma |
frameshift_variant |
3.448% (5/145) |
1 entry |
ENSG00000136492 |
BRIP1 |
skin melanoma |
stop_gained |
3.02% (35/1159) |
1 entry |
ENSG00000136492 |
BRIP1 |
small cell lung carcinoma |
sequence_alteration |
1.121% (5/446) |
2 entries |
ENSG00000136492 |
BRIP1 |
prostate carcinoma |
sequence_alteration |
1.86% (9/484) |
2 entries |
ENSG00000136492 |
BRIP1 |
ovarian serous adenocarcinoma |
sequence_alteration |
2.162% (19/879) |
2 entries |
ENSG00000136492 |
BRIP1 |
breast ductal adenocarcinoma |
frameshift_variant |
6.448% (102/1582) |
1 entry |
ENSG00000136492 |
BRIP1 |
lung adenocarcinoma |
stop_gained |
2.017% (52/2578) |
3 entries |
ENSG00000136492 |
BRIP1 |
cecum adenocarcinoma |
missense_variant |
3.717% (10/269) |
3 entries |
ENSG00000136492 |
BRIP1 |
breast carcinoma |
missense_variant |
1.085% (16/1474) |
1 entry |
ENSG00000136492 |
BRIP1 |
colon adenocarcinoma |
sequence_alteration |
2.401% (31/1291) |
2 entries |
ENSG00000136492 |
BRIP1 |
rectal adenocarcinoma |
missense_variant |
0.7326% (4/546) |
1 entry |
ENSG00000136492 |
BRIP1 |
ovarian serous adenocarcinoma |
missense_variant |
2.162% (19/879) |
2 entries |
ENSG00000136492 |
BRIP1 |
papillary thyroid carcinoma |
missense_variant |
0.409% (2/489) |
1 entry |
ENSG00000136492 |
BRIP1 |
cecum adenocarcinoma |
stop_gained |
3.717% (10/269) |
1 entry |
ENSG00000136492 |
BRIP1 |
clear cell renal carcinoma |
missense_variant |
0.379% (6/1583) |
2 entries |
ENSG00000136492 |
BRIP1 |
colorectal adenocarcinoma |
missense_variant |
2.556% (31/1213) |
2 entries |
ENSG00000136492 |
BRIP1 |
bladder transitional cell carcinoma |
stop_gained |
1.794% (8/446) |
1 entry |
ENSG00000136492 |
BRIP1 |
glioma |
missense_variant |
0.1669% (1/599) |
1 entry |
ENSG00000136492 |
BRIP1 |
adenosquamous lung carcinoma |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000136492 |
BRIP1 |
primary peritoneal carcinoma (disease) |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000136492 |
BRIP1 |
gastric intestinal type adenocarcinoma |
missense_variant |
2.353% (2/85) |
1 entry |
ENSG00000136492 |
BRIP1 |
diffuse large B-cell lymphoma |
conservative_inframe_deletion |
0.5405% (2/370) |
1 entry |
ENSG00000136492 |
BRIP1 |
gastric adenocarcinoma |
stop_gained |
0.8345% (6/719) |
1 entry |
ENSG00000136492 |
BRIP1 |
small intestinal adenocarcinoma |
missense_variant |
4.762% (1/21) |
1 entry |
ENSG00000136492 |
BRIP1 |
brain glioblastoma |
sequence_alteration |
0.495% (6/1212) |
1 entry |
ENSG00000136492 |
BRIP1 |
colorectal adenocarcinoma |
conservative_inframe_deletion |
2.556% (31/1213) |
1 entry |
ENSG00000136492 |
BRIP1 |
bronchoalveolar adenocarcinoma |
stop_gained |
9.091% (2/22) |
1 entry |
ENSG00000136492 |
BRIP1 |
laryngeal squamous cell carcinoma |
missense_variant |
4.878% (2/41) |
1 entry |
ENSG00000136492 |
BRIP1 |
colon adenocarcinoma |
stop_gained |
2.401% (31/1291) |
1 entry |
ENSG00000136492 |
BRIP1 |
angiosarcoma |
sequence_alteration |
2.128% (1/47) |
1 entry |
ENSG00000136492 |
BRIP1 |
gastric intestinal type adenocarcinoma |
frameshift_variant |
2.353% (2/85) |
1 entry |
ENSG00000136492 |
BRIP1 |
prostate carcinoma |
missense_variant |
1.86% (9/484) |
1 entry |
ENSG00000136492 |
BRIP1 |
adrenocortical adenoma |
missense_variant |
2.439% (1/41) |
1 entry |
ENSG00000136492 |
BRIP1 |
Anal Squamous Cell Carcinoma |
missense_variant |
1.22% (1/82) |
1 entry |
ENSG00000136492 |
BRIP1 |
large cell lung carcinoma |
missense_variant |
5.263% (1/19) |
1 entry |
ENSG00000136492 |
BRIP1 |
neoplasm |
missense_variant |
3.571% (1/28) |
1 entry |
ENSG00000136492 |
BRIP1 |
Endometrial Endometrioid Adenocarcinoma |
frameshift_variant |
3.87% (25/646) |
1 entry |
ENSG00000136492 |
BRIP1 |
nasopharyngeal squamous cell carcinoma |
missense_variant |
0.5556% (1/180) |
1 entry |
ENSG00000136492 |
BRIP1 |
small cell lung carcinoma |
stop_gained |
1.121% (5/446) |
1 entry |
ENSG00000136492 |
BRIP1 |
basal cell carcinoma |
sequence_alteration |
4.412% (3/68) |
1 entry |
ENSG00000136492 |
BRIP1 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
stop_gained |
0.3788% (1/264) |
1 entry |
ENSG00000136492 |
BRIP1 |
Gallbladder Adenocarcinoma |
sequence_alteration |
1.227% (2/163) |
1 entry |
ENSG00000136492 |
BRIP1 |
Gallbladder Adenocarcinoma |
missense_variant |
1.227% (2/163) |
1 entry |
ENSG00000136492 |
BRIP1 |
Adrenal Gland Neuroblastoma |
missense_variant |
1.667% (1/60) |
1 entry |
ENSG00000136492 |
BRIP1 |
non-small cell lung carcinoma |
missense_variant |
0.9524% (1/105) |
1 entry |
ENSG00000136492 |
BRIP1 |
bronchoalveolar adenocarcinoma |
missense_variant |
9.091% (2/22) |
1 entry |
ENSG00000136492 |
BRIP1 |
head and neck squamous cell carcinoma |
frameshift_variant |
0.8011% (6/749) |
1 entry |
ENSG00000136492 |
BRIP1 |
Merkel cell skin cancer |
missense_variant |
1.075% (1/93) |
1 entry |
ENSG00000136492 |
BRIP1 |
Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
conservative_inframe_deletion |
3.03% (1/33) |
1 entry |
ENSG00000136492 |
BRIP1 |
bladder transitional cell carcinoma |
frameshift_variant |
1.794% (8/446) |
1 entry |
ENSG00000136492 |
BRIP1 |
hemangioblastoma |
missense_variant |
2.857% (1/35) |
1 entry |
ENSG00000136492 |
BRIP1 |
clear cell renal carcinoma |
sequence_alteration |
0.379% (6/1583) |
1 entry |
ENSG00000136492 |
BRIP1 |
Malignant Urinary System Neoplasm |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000136492 |
BRIP1 |
metaplastic breast carcinoma |
missense_variant |
3.333% (2/60) |
1 entry |
ENSG00000136492 |
BRIP1 |
endometrial carcinoma |
stop_gained |
4.167% (1/24) |
1 entry |
ENSG00000136492 |
BRIP1 |
laryngeal squamous cell carcinoma |
sequence_alteration |
4.878% (2/41) |
1 entry |
ENSG00000136492 |
BRIP1 |
squamous cell lung carcinoma |
stop_gained |
1.005% (10/995) |
1 entry |
ENSG00000136492 |
BRIP1 |
esophageal squamous cell carcinoma |
sequence_alteration |
1.308% (9/688) |
1 entry |
ENSG00000136492 |
BRIP1 |
oral squamous cell carcinoma |
missense_variant |
0.3817% (1/262) |
1 entry |
ENSG00000136492 |
BRIP1 |
brain astrocytoma |
missense_variant |
2.083% (1/48) |
1 entry |